T-cell receptor gene therapy of established tumors in a murine melanoma model
about
T cell receptor gene therapy for cancerAdoptive cell transfer: a clinical path to effective cancer immunotherapyAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaHuman antigen-specific regulatory T cells generated by T cell receptor gene transfer.Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cellsCancer immunotherapy: in vivo imaging of adoptively transferred T cells in an immunocompetent host.Redirecting the immune response: role of adoptive T cell therapy.Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.The immune response to melanoma is limited by thymic selection of self-antigensDendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationGenetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells.Selective expansion and enhanced anti-tumor effect of antigen-specific CD4(+) T cells by retrovirus-mediated IL-15 expressionSimultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice.Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras.Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionSuppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.Genetic redirection of T cells for cancer therapy.Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.Immune and molecular correlates in melanoma treated with immune checkpoint blockade.TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsCD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.A Synthetic CD8α:MyD88 Coreceptor Enhances CD8+ T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens.GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.
P2860
Q24634774-E251274D-D54C-4056-B4C6-DB155FB8372BQ24644774-000EAA7D-359F-4ABA-9A0A-D79E0A704BD0Q28749871-8D04C7DE-792C-4F68-84AD-96198C010785Q33644234-A2FE51B4-7880-4807-8AE3-5DE442EBB511Q33801773-00FD02B3-7F13-4828-B40E-DDF69239C951Q34069877-830FE95A-F412-4EE1-8107-4B234C0645C2Q34123238-C13FB45E-6C29-453B-AEAF-CF5AB60B7540Q34170012-610A0A35-BE78-482A-A171-D12E9F1D39B5Q34233795-5FE67D76-2488-4795-9E3A-4CFBD6995881Q34759603-FD09E709-026F-4A7C-9A3B-6A0EAEDAEFD1Q35001971-09E30489-E5FF-463B-9FDC-4FC4D44860C5Q35144751-2041F80F-3111-4B6A-B7A1-9AC16D469C8AQ36102927-4775AD1C-C8C1-45D1-9349-505E66C90D45Q36922752-1577689C-8827-4308-A99C-8AD82FCBD85BQ36938866-7C99B4A9-ADFC-4BF8-BE7B-C74BCDAA3A2CQ37036104-9C8C91E1-FFC3-4E8E-A323-286E059C8D25Q37197942-4685F231-9863-4943-BE0D-050571EB0E11Q37455362-4FFC0E18-D232-43B6-A9C7-259F354C723FQ37697337-6AB894B1-5BE8-4D26-AD9F-A5D628B9C522Q37747066-2EEE28B4-62C0-4608-B2D3-DC914B65966EQ39329603-E390E0EC-D517-48BB-A744-C4AD28088AF4Q41837100-C0C59214-3B5B-4CD8-91B0-5BA93B2D1031Q42136462-65129CED-56DB-4053-897C-938623D078E8Q43538607-DBC2DBB1-9DB6-4391-83D9-4F4A869D2575Q45873576-166F281F-FB97-45FD-9699-EED117D1F041Q47621514-F5313DD6-81F1-47DC-A6F7-C33D9A5772FFQ55353959-BD4D56E7-20F5-406C-9465-2AECF404B057
P2860
T-cell receptor gene therapy of established tumors in a murine melanoma model
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
T-cell receptor gene therapy of established tumors in a murine melanoma model
@ast
T-cell receptor gene therapy of established tumors in a murine melanoma model
@en
type
label
T-cell receptor gene therapy of established tumors in a murine melanoma model
@ast
T-cell receptor gene therapy of established tumors in a murine melanoma model
@en
prefLabel
T-cell receptor gene therapy of established tumors in a murine melanoma model
@ast
T-cell receptor gene therapy of established tumors in a murine melanoma model
@en
P2093
P2860
P50
P1476
T-cell receptor gene therapy of established tumors in a murine melanoma model
@en
P2093
Annelies Jorritsma
Chrystal M Paulos
Claudia Wrzensinski
John B A G Haanen
John D Abad
Luca Gattinoni
Moniek A De Witte
Richard A Morgan
Steven A Rosenberg
P2860
P356
10.1097/CJI.0B013E31815C193F
P577
2008-01-01T00:00:00Z